$457 Million is the total value of Essex Woodlands Management, Inc.'s 9 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 22.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AXGN | AXOGEN INC | $135,456,000 | +29.0% | 3,711,111 | 0.0% | 29.64% | +56.2% | |
| RVNC | REVANCE THERAPEUTICS INC | $118,335,000 | -13.8% | 3,842,047 | 0.0% | 25.90% | +4.3% | |
| CORI | CORIUM | $107,282,000 | +19.4% | 9,353,304 | 0.0% | 23.48% | +44.5% | |
| ABMD | Sell | ABIOMED INC | $58,727,000 | -51.6% | 201,818 | -68.8% | 12.85% | -41.3% |
| MNOV | MEDICINOVA INC | $11,961,000 | +58.0% | 1,170,370 | 0.0% | 2.62% | +91.2% | |
| ELGX | ENDOLOGIX INC | $11,583,000 | -9.2% | 1,257,468 | 0.0% | 2.54% | +9.9% | |
| PSDV | New | PSIVIDA | $10,500,000 | – | 8,606,324 | +100.0% | 2.30% | – |
| CBIO | CATALYST | $2,110,000 | +93.4% | 78,622 | 0.0% | 0.46% | +134.5% | |
| ACUR | ACURA PHARMACEUTICALS INC | $998,000 | +27.5% | 1,956,397 | 0.0% | 0.22% | +53.5% | |
| ENTL | Exit | ENTELLUS MEDICAL INC | $0 | – | -3,231,656 | -100.0% | -14.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MEDICINOVA INC | 42 | Q3 2023 | 6.5% |
| REVANCE THERAPEUTICS INC | 39 | Q3 2023 | 44.6% |
| AXOGEN INC | 26 | Q4 2021 | 43.3% |
| ENDOLOGIX INC | 24 | Q1 2019 | 22.5% |
| ABIOMED INC | 20 | Q1 2018 | 52.1% |
| CORIUM INTL INC | 20 | Q1 2019 | 23.5% |
| TELA BIO, INC. | 16 | Q3 2023 | 31.5% |
| VENUS CONCEPT, INC. | 16 | Q3 2023 | 21.3% |
| ACURA PHARMACEUTICALS INC | 15 | Q1 2019 | 1.4% |
| CATALYST BIOSCIENCES INC | 15 | Q1 2019 | 1.0% |
View Essex Woodlands Management, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Essex Woodlands Management, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.